Lupin reported INR30.4B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Bharat Petroleum INR 137.44B 131.86B Sep/2025
Cipla INR 7.96B 39.9M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025